nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment of intrafractional prostate motion and its dosimetric impact in MRI-guided online adaptive radiotherapy with gating
|
Xiong, Yuqing |
|
|
199 |
6 |
p. 544-553 |
artikel |
2 |
Brooke–Spiegler syndrome: radiotherapy as the last resort?
|
Sweeney, Reinhart A. |
|
|
199 |
6 |
p. 595-600 |
artikel |
3 |
Clinical outcome in metastatic prostate cancer after primary radiotherapy
|
Moll, Matthias |
|
|
199 |
6 |
p. 536-543 |
artikel |
4 |
Gute Therapieverträglichkeit und Lebensqualität nach primär organerhaltender Therapie des frühen Rektumkarzinoms: Ergebnisse der TREC-Studie
|
Wurschi, Georg W. |
|
|
199 |
6 |
p. 601-603 |
artikel |
5 |
Linac-based stereotactic salvage reirradiation for intraprostatic prostate cancer recurrence: toxicity and outcomes
|
Cozzi, Salvatore |
|
|
199 |
6 |
p. 554-564 |
artikel |
6 |
Preoperative radiotherapy with concomitant chemotherapy in extremity soft tissue sarcomas: long-term results of a single center
|
Yilmaz, Ugur |
|
|
199 |
6 |
p. 585-594 |
artikel |
7 |
Präoperative Therapie beim Pankreaskarzinom: Daten der A021501-Studie
|
Paal, Katarzyna |
|
|
199 |
6 |
p. 607-610 |
artikel |
8 |
Re-Bestrahlung und Bevacizumab – wirksame Partner bei rezidiviertem Glioblastom
|
Seidel, Clemens |
|
|
199 |
6 |
p. 604-606 |
artikel |
9 |
Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial
|
Krug, David |
|
|
199 |
6 |
p. 565-573 |
artikel |
10 |
Safety and efficacy associated with single-fraction high-dose-rate brachytherapy in localized prostate cancer: a systematic review and meta-analysis
|
Zeng, Hong |
|
|
199 |
6 |
p. 525-535 |
artikel |
11 |
Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer
|
Rosenbrock, Johannes |
|
|
199 |
6 |
p. 574-584 |
artikel |